American Shared Hospital Services (AMS)

American Shared Hospital Services experienced several stock events in the past six months. The Q3 2025 earnings report showed revenue and adjusted EBITDA increases, and a 10-year extension was announced. A debt misclassification and default notice impacted the stock negatively. A PBRT lease extension was announced. The Q4 and full-year 2025 results showed a revenue decrease due to contract expirations and lower PBRT volumes. The CEO resigned, and an interim CEO was appointed. The stock price declined by 36.57% between May 5, 2025, and May 1, 2026.

Specific demand seasonality for American Shared Hospital Services' products and services is not explicitly detailed. Demand is generally less subject to strong seasonal fluctuations. Fluctuations in revenue are more influenced by operational factors such as new treatment centers, contract changes, and international expansion.

American Shared Hospital Services (AMS) operates in the Healthcare sector, providing advanced radiation therapy and radiosurgery equipment and services. The company offers Gamma Knife systems, Proton Beam Radiation Therapy (PBRT), Linear Accelerators (LINACs), Brachytherapy systems, and Direct Patient Services.

American Shared Hospital Services operates in the United States and internationally. Key locations include a joint venture for PBRT in Orlando, Florida, and cancer centers in Rhode Island. Internationally, they have a treatment center in Puebla, Mexico, with a planned startup in Guadalajara, Mexico, and facilities in Peru and Ecuador.

American Shared Hospital Services' brand reputation was potentially impacted by the announcement of a debt misclassification and a default notice from its lender. Although the company stated the error did not affect key financial metrics, such disclosures can negatively affect investor and partner confidence.

American Shared Hospital Services has a mixed ownership structure. Institutional investors hold approximately 23.16% to 23.78% of the stock, insiders hold around 23.80% to 24.65%, and retail investors hold approximately 63.22%. Major institutional owners include Dimensional Fund Advisors Lp and Vanguard Group Inc. Raymond Stachowiak owns the most shares.